Breast cancer is currently the second greatest cause of cancer-related death in women living in the United States, with approximately 40,000 women dying annually from complications of breast cancer. 1 As a result of both earlier detection through
Search Results
Differences in Patient Screening Mammography Rates Associated With Internist Gender and Level of Training and Change Following the 2009 U.S. Preventive Services Task Force Guidelines
Dawn J. Brooks
Routine Imaging or No Routine Imaging, Is That the Question?
Laurie Elit, Gregory R. Pond, and Mark N. Levine
interventions exist that can alter the clinical course of the disease. Otherwise, the only impact of early detection is to give the patient more time with the disease (lead-time bias). Introducing potentially toxic treatments such as chemotherapy to asymptomatic
Appropriate Use of Imaging to Detect Primary, Second Primary, and Recurrent Breast Cancer
Bethany L. Niell
, recurrent, or second primary breast cancers before symptoms develop, because early detection results in decreased mortality and treatment morbidity. Although screening mammography decreases breast cancer mortality by 20% to 40%, only 58% of women aged 40 to
Molecular Tests in Pancreatic Cancer: Critical Role of Molecular Testing, Expanding Access, and Adherence to the NCCN Guidelines for Pancreatic Cancer
Nirag Jhala, Jeffrey Petersen, and Darshana Jhala
pancreatic carcinoma, developing surveillance strategies around early detection of pancreatic carcinoma, and providing precision therapeutic options to impact survival outcomes. In their study of 368 patients with pancreatic adenocarcinoma (125 patients
NCCN News
, University of Michigan, Network Genome-Wide Association Studies for Early Detection of Cancers In addition, the following past recipients presented their findings as part of the oral and poster presentations at the NCCN 2019 Annual Conference: Saad Kenderian
Colon Cancer Screening Continues as Pivotal to Cancer Prevention
Randall W. Burt
screening is somewhat unique compared with currently recommended cancer screening programs, because it is to a large extent prevention, although early detection is also provided. Several studies have shown it to be as or even more cost-effective than other
Reply to ‘It May be Time to Abandon Urine Tests for Bladder Cancer’
Hideki Furuya and Charles J. Rosser
effective cancer risk assessment, early detection, and early diagnosis of bladder cancer, ushering in a new era in bladder cancer diagnosis. Call for Correspondence JNCCN is committed to providing a forum to enhance collaboration between academic
NCCN Virtual Policy Summit: Defining the “New Normal” — 2021 and the State of Cancer Care in America Following 2020
Alyssa A. Schatz, Lindsey Bandini, and Robert W. Carlson
Appendix 1 . Impact of COVID-19 on Cancer Treatment and Early Detection Throughout March and April of 2020, state and local government officials issued shelter-in-place orders to mitigate the spread of COVID-19. As a result, cancer research
I Can’t Breathe!
Margaret Tempero
across many cancers and where black and brown people frequently face many barriers in access to care for prevention and early detection. This should be something we think about every day. More importantly, we should put our words into action. Begin by
Incident Cancer Detection During the COVID-19 Pandemic
Antoine Eskander, Qing Li, Jiayue Yu, Julie Hallet, Natalie G. Coburn, Anna Dare, Kelvin K.W. Chan, Simron Singh, Ambica Parmar, Craig C. Earle, Lauren Lapointe-Shaw, Monika K. Krzyzanowska, Timothy P. Hanna, Antonio Finelli, Alexander V. Louie, Nicole Look Hong, Jonathan C. Irish, Ian J. Witterick, Alyson Mahar, Christopher W. Noel, David R. Urbach, Daniel I. McIsaac, Danny Enepekides, and Rinku Sutradhar
Background Cancer survival rates have improved over the past decade, in part because of earlier detection of disease. 1 , 2 However, screening programs with accessible in-person care have been impacted by the emergency health measures put in
